MAIZEL ARI (Chief Commercial Officer) sold 7.50K shares of AXSOME THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.37M. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/24/2026ACC: 0001193125-26-174415
Officer· Chief Commercial Officer
Since Feb 2026
-7.50K
Net shares
Net seller
$1.37M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
7.50K acquired · 15K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+7.50K
Price / share
$70.73
Trade value
$530.48K
% of position
New position
4/22/2026
0.00→7.50K
Common Stock
Direct
Shares
−7.50K
Price / share
$182.42
Trade value
$1.37M
% of position
New position
4/22/2026
7.50K→0.00
Total
Net shares
+0.00
Net value
-$837.67K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/22/2026 | M · Option Exercise | +7.50K | $70.73 | $530.48K | New position | 0.00 | 7.50K |
| Common Stock Direct | 4/22/2026 | S · Sale | −7.50K | $182.42 | $1.37M | New position | 7.50K | 0.00 |
| Total | +0.00 | -$837.67K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
7.50K shares
Shares
−7.50K
Strike price
70.73
Held after
23.71K
Exercisable
—
4/22/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock7.50K shares | 4/22/2026 | M · Option Exercise | −7.50K | 70.73 | — | 23.71K |